MARCH8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.171630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.443200E-01
Normal-vs-Stage2
3.689600E-02
Normal-vs-Stage3
6.942300E-02
Normal-vs-Stage4
4.596800E-01
Stage1-vs-Stage2
1.784380E-01
Stage1-vs-Stage3
7.875600E-02
Stage1-vs-Stage4
9.784600E-01
Stage2-vs-Stage3
2.752400E-01
Stage2-vs-Stage4
2.517600E-01
Stage3-vs-Stage4
3.142400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.236570E-01
Normal-vs-AfricanAmerican
4.669800E-01
Normal-vs-Asian
2.873800E-02
Caucasian-vs-AfricanAmerican
3.910400E-01
Caucasian-vs-Asian
1.406610E-01
AfricanAmerican-vs-Asian
6.533600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.091900E-02
Normal-vs-Female
1.874400E-01
Male-vs-Female
3.861200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.759800E-01
Normal-vs-Age(41-60Yrs)
2.665800E-01
Normal-vs-Age(61-80Yrs)
9.198200E-02
Normal-vs-Age(81-100Yrs)
2.126500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.979600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.646800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.585400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.454580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.011640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.424100E-03
Normal-vs-Daily Drinker
1.340160E-02
Normal-vs-Weekly Drinker
5.225600E-02
Normal-vs-Occasional Drinker
4.120800E-01
Normal-vs-Social Drinker
6.229000E-01
Non Drinker-vs-Daily Drinker
8.209800E-01
Non Drinker-vs-Weekly Drinker
7.950600E-01
Non Drinker-vs-Occasional Drinker
1.104000E-01
Non Drinker-vs-Social Drinker
1.560970E-01
Daily Drinker-vs-Weekly Drinker
9.417200E-01
Daily Drinker-vs-Occasional Drinker
1.454610E-01
Daily Drinker-vs-Social Drinker
1.851190E-01
Weekly Drinker-vs-Occasional Drinker
2.264200E-01
Weekly Drinker-vs-Social Drinker
2.182200E-01
Occasional Drinker-vs-Social Drinker
7.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.187800E-01
Normal-vs-Grade 2
1.220610E-01
Normal-vs-Grade 3
5.186000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.016400E-01
Grade 1-vs-Grade 3
2.937600E-01
Grade 1-vs-Grade 4
2.187800E-01
Grade 2-vs-Grade 3
6.780600E-01
Grade 2-vs-Grade 4
1.220610E-01
Grade 3-vs-Grade 4
5.186000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.220200E-02
Normal-vs-NonDiabetic
1.075830E-01
Diabetic-vs-NonDiabetic
9.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.221800E-01
Normal-vs-NoPancreatitis
1.229040E-01
Pancreatitis-vs-NoPancreatitis
4.148000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.136600E-01
Normal-vs-N1
4.304000E-02
N0-vs-N1
3.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.281000E-01
Normal-vs-TP53-NonMutant
6.112400E-01
TP53-Mutant-vs-TP53-NonMutant
2.616400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
